LIFE SCIENCE AND HEALTH INVESTOR LUNCH at SLUSH 2017
30th of November 2017
Cerenion Oy is one of only 20 companies invited to present to a group of international investors at the Life Science and Health Investor Lunch, taking place on November 30th 2017 in Helsinki, Finland.
The event organized by Tech Tour, Health Capital Helsinki, Finpro and Tekes in collaboration with Slush will take place at Messukeskus as a side event of SLUSH 2017. The lunch will bring together highly promising preselected life science and health startups with international investors focusing on biotech, pharma, diagnostics, personalized medicine, remote monitoring and diagnosis, as well as other life science sectors.
Cerenion Oy will be represented by Dr. Timo Koskela, CEO and Co-founder, at the event. If you would like to arrange a meeting with us at the event please contact Timo directly.